Study of Neoadjuvant Regimen for Radioactive Iodine Treatment of Metastatic and Advanced Differentiated Thyroid Cancers

NCT04180007 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

10

Enrollment

OTHER

Sponsor class

Conditions

Thyroid
Metastasis
Apatinib

Interventions

DRUG: Apatinib

Sponsor

Nanjing First Hospital, Nanjing Medical University